Novo Nordisk to end German sales of new insulin drug after price row

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing.